Virani Shafique has filed 53 insider transactions across 1 company since January 2023.
Most recent transaction: a option exercise of 18000 shares of RECURSION PHARMACEUTICALS, INC. ($RXRX) on January 16, 2024.
Activity breakdown: 0 open-market purchases and 17 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 16, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | M | Class A Common Stock | 18000 | $2.22 | 154,748.0000 | 0 | 13.16% | 0.00% |
| Jan. 16, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | S | Class A Common Stock | 18000 | $10.93 | 136,748.0000 | 0 | 11.63% | 0.00% |
| Jan. 16, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | M | Stock Option (Right to Buy) | 18000 | $0.00 | 659,862.0000 | 0 | 2.66% | 0.00% |
| Dec. 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | M | Class A Common Stock | 18000 | $2.22 | 154,748.0000 | 0 | 13.16% | 0.00% |
| Dec. 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | S | Class A Common Stock | 18000 | $9.60 | 136,748.0000 | 0 | 11.63% | 0.00% |
| Dec. 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | M | Stock Option (Right to Buy) | 18000 | $0.00 | 677,862.0000 | 0 | 2.59% | 0.00% |
| Nov. 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | M | Class A Common Stock | 18000 | $2.22 | 158,351.0000 | 0 | 12.82% | 0.00% |
| Nov. 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | S | Class A Common Stock | 18000 | $6.51 | 140,351.0000 | 0 | 11.37% | 0.00% |
| Nov. 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | F | Class A Common Stock | 3603 | $7.18 | 136,748.0000 | 0 | 2.57% | 0.00% |
| Nov. 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | M | Stock Option (Right to Buy) | 18000 | $0.00 | 695,862.0000 | 0 | 2.52% | 0.00% |
| Oct. 16, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | M | Class A Common Stock | 18000 | $2.22 | 158,351.0000 | 0 | 12.82% | 0.00% |
| Oct. 16, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | S | Class A Common Stock | 18000 | $6.30 | 140,351.0000 | 0 | 11.37% | 0.00% |
| Oct. 16, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | M | Stock Option (Right to Buy) | 18000 | $0.00 | 713,862.0000 | 0 | 2.46% | 0.00% |
| Sept. 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | M | Class A Common Stock | 18000 | $2.22 | 158,351.0000 | 0 | 12.82% | 0.00% |
| Sept. 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | S | Class A Common Stock | 18000 | $8.66 | 140,351.0000 | 0 | 11.37% | 0.00% |
| Sept. 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | M | Stock Option (Right to Buy) | 18000 | $0.00 | 731,862.0000 | 0 | 2.40% | 0.00% |
| Aug. 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | F | Class A Common Stock | 3603 | $9.19 | 140,351.0000 | 0 | 2.50% | 0.00% |
| Aug. 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | M | Class A Common Stock | 18000 | $2.22 | 158,351.0000 | 0 | 12.82% | 0.00% |
| Aug. 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | S | Class A Common Stock | 18000 | $9.25 | 140,351.0000 | 0 | 11.37% | 0.00% |
| Aug. 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | M | Stock Option (Right to Buy) | 18000 | $0.00 | 749,862.0000 | 0 | 2.34% | 0.00% |
| July 25, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | M | Class A Common Stock | 20000 | $2.22 | 163,954.0000 | 0 | 13.89% | 0.00% |
| July 25, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | S | Class A Common Stock | 20000 | $14.30 | 143,954.0000 | 0 | 12.20% | 0.00% |
| July 26, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | M | Class A Common Stock | 20000 | $2.22 | 163,954.0000 | 0 | 13.89% | 0.00% |
| July 26, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | S | Class A Common Stock | 20000 | $14.41 | 143,954.0000 | 0 | 12.20% | 0.00% |
| July 25, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | M | Stock Option (Right to Buy) | 20000 | $0.00 | 787,862.0000 | 0 | 2.48% | 0.00% |
| July 26, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | M | Stock Option (Right to Buy) | 20000 | $0.00 | 767,862.0000 | 0 | 2.54% | 0.00% |
| July 17, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | M | Class A Common Stock | 30000 | $2.22 | 173,954.0000 | 0 | 20.84% | 0.00% |
| July 17, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | S | Class A Common Stock | 30000 | $11.72 | 143,954.0000 | 0 | 17.25% | 0.00% |
| July 18, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | M | Class A Common Stock | 30000 | $2.22 | 173,954.0000 | 0 | 20.84% | 0.00% |
| July 18, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | S | Class A Common Stock | 30000 | $13.74 | 143,954.0000 | 0 | 17.25% | 0.00% |
| July 17, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | M | Stock Option (Right to Buy) | 30000 | $0.00 | 837,862.0000 | 0 | 3.46% | 0.00% |
| July 18, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | M | Stock Option (Right to Buy) | 30000 | $0.00 | 807,862.0000 | 0 | 3.58% | 0.00% |
| June 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | M | Class A Common Stock | 30000 | $2.22 | 173,954.0000 | 0 | 20.84% | 0.00% |
| June 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | S | Class A Common Stock | 30000 | $9.67 | 143,954.0000 | 0 | 17.25% | 0.00% |
| June 16, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | M | Class A Common Stock | 30000 | $2.22 | 173,954.0000 | 0 | 20.84% | 0.00% |
| June 16, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | S | Class A Common Stock | 30000 | $9.41 | 143,954.0000 | 0 | 17.25% | 0.00% |
| June 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | M | Stock Option (Right to Buy) | 30000 | $0.00 | 897,862.0000 | 0 | 3.23% | 0.00% |
| June 16, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | M | Stock Option (Right to Buy) | 30000 | $0.00 | 867,862.0000 | 0 | 3.34% | 0.00% |
| June 1, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | S | Class A Common Stock | 25000 | $8.58 | 161,819.0000 | 0 | 13.38% | 0.00% |
| June 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | S | Class A Common Stock | 17865 | $8.93 | 143,954.0000 | 0 | 11.04% | 0.00% |
| May 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | F | Class A Common Stock | 2230 | $5.60 | 185,102.0000 | 0 | 1.19% | 0.00% |
| Feb. 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | M | Class A Common Stock | 7486 | $2.22 | 197,332.0000 | 0 | 3.94% | 0.00% |
| Feb. 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | S | Class A Common Stock | 7486 | $8.33 | 189,846.0000 | 0 | 3.79% | 0.00% |
| Feb. 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | F | Class A Common Stock | 746 | $8.44 | 189,100.0000 | 0 | 0.39% | 0.00% |
| Feb. 16, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | S | Class A Common Stock | 1768 | $8.42 | 187,332.0000 | 0 | 0.93% | 0.00% |
| Feb. 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | M | Stock Option (Right to Buy) | 7486 | $0.00 | 927,862.0000 | 0 | 0.81% | 0.00% |
| Feb. 1, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | A | Class A Common Stock | 106253 | $0.00 | 182,003.0000 | 0 | 140.27% | 0.00% |
| Feb. 1, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | A | Class A Common Stock | 10837 | $0.00 | 192,840.0000 | 0 | 5.95% | 0.00% |
| Feb. 1, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | F | Class A Common Stock | 2994 | $8.55 | 189,846.0000 | 0 | 1.55% | 0.00% |
| Feb. 1, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | A | Stock Option (Right to Buy) | 212507 | $0.00 | 935,348.0000 | 0 | 29.40% | 0.00% |
| Jan. 17, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | M | Class A Common Stock | 5000 | $2.22 | 83,160.0000 | 0 | 6.40% | 0.00% |
| Jan. 17, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | S | Class A Common Stock | 10000 | $9.16 | 73,160.0000 | 0 | 12.03% | 0.00% |
| Jan. 17, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Virani Shafique | Chief Business Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 722,841.0000 | 0 | 0.69% | 0.00% |